Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery

The global pandemic of COVID-19 is a serious public health concern. Over 625 million confirmed cases and more than 6 million deaths have been recorded worldwide. Although several vaccines and antiviral medications have been developed, their efficacy is limited by the emerging new SARS-CoV-2 strains....

Descripción completa

Detalles Bibliográficos
Autores principales: Essa, Raahilah Zahir, Wu, Yuan-seng, Batumalaie, Kalaivani, Sekar, Mahendran, Poh, Chit-laa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Special Issue: Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676828/
https://www.ncbi.nlm.nih.gov/pubmed/36401119
http://dx.doi.org/10.1007/s43440-022-00432-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676828/
https://www.ncbi.nlm.nih.gov/pubmed/36401119
http://dx.doi.org/10.1007/s43440-022-00432-6

Ejemplares similares